{"filing":{"accession_number":"0001213900-26-090766","cik":"0002023016","ticker":"TTRX","company_name":"Turn Therapeutics Inc.","form":"8-K","filing_date":"2026-08-17","report_date":"2026-08-14","primary_document":"ea0302457-8k_turn.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2023016/000121390026090766/ea0302457-8k_turn.htm"},"events":[{"id":28257,"run_id":25838,"accession_number":"0001213900-26-090766","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Turn Therapeutics entered into securities purchase agreements on August 14, 2026 to issue and sell 135,000 shares of common stock at $10.00 per share for $1.35 million aggregate gross proceeds in a private placement relying on Section 4(a)(2) and Regulation D exemptions. This is a classic unregistered equity issuance to accredited investors that dilutes existing shareholders and raises capital, fitting the dilutive_issuance category. The company also granted registration rights to the investors, further evidencing the nature of this transaction.","company_name":"Turn Therapeutics Inc.","ticker":"TTRX","filing_date":"2026-08-17","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":30141,"accession_number":"0001213900-26-090766","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Turn Therapeutics entered into securities purchase agreements on August 14, 2026 to issue and sell 135,000 shares of common stock at $10.00 per share for $1.35 million aggregate gross proceeds in a private placement relying on Section 4(a)(2) and Regulation D exemptions. This is a classic unregistered equity issuance to accredited investors that dilutes existing shareholders and raises capital, fitting the dilutive_issuance category. The company also granted registration rights to the investors, further evidencing the nature of this transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T20:17:37.216456+00:00","company_name":"Turn Therapeutics Inc.","ticker":"TTRX","filing_date":"2026-08-17"}]}